Tag: antibiotics


What happened to all the antibiotics?

January 30, 2023

Via: Pharmaphorum

In many countries across the world, there are shortages of common antibiotics. The problems have been reported across many countries in Europe, in the US, Canada, and Australia. Though the shortages have been more widely reported in more economically developed […]

Industry, Pharma

As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger

July 15, 2022

Via: Kaiser Health News

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics. There’s […]


Is Childhood Vaccination Disrupted by Excessive Use of Antibiotics?

May 16, 2022

Via: Natalie Dunn

Nothing could make the benefits of vaccination easier to understand than the recent COVID-19 pandemic and its catastrophic effects. However, when it comes to vaccinating children and teenagers, many people around the world showed reluctance due to the potential negative […]

Industry, Pharma

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that.

February 1, 2022

Via: Biopharma Dive

Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more deaths worldwide than HIV/AIDS and malaria combined. Yet the pharmaceutical industry has been slow to […]

Manufacturing, Research and Development

New Compounds Block Antimicrobial Resistance to Last Resort Antibiotics

December 14, 2021

Via: Genetic Engineering and Biotechnology News

Scientists have discovered a new potential treatment that could reverse antibiotic resistance in different Gram-negative bacteria that cause conditions including urinary tract infections, sepsis, or pneumonia. The collaborative research, headed by a team at the Ineos Oxford Institute (IOI) for […]

Biotech, Industry

Bacteriophage and Antibiotic Combined to Fight Drug-Resistant Infection

September 20, 2021

Via: Genetic Engineering and Biotechnology News

Researchers from the Université de Montpellier, France, and the University of Pittsburgh, have published a study (“Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus”) in Disease Models & Mechanisms that describes the antibacterial effects of treating infections caused by […]

FDA, Regulations

‘Anti-antibiotic’ allows for use of antibiotics without driving resistance

December 1, 2020

Via: ScienceDaily

An inexpensive, FDA-approved drug — cholestyramine — taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. “Antimicrobial resistance is a serious problem […]

Biotech, Cell and Gene Therapy, Industry, News

Novel Antibiotics May Result from Bacterial Cell Wall Study

May 1, 2020

Via: Genetic Engineering and Biotechnology News

Scientists from the University of Leeds say they have identified a key process in the way bacteria protect themselves from attack and that their finding heralds a potential new strategy in the hunt for antibiotics. The researchers pieced together how […]

Biotech, Clinical Trials, Industry, Research and Development, Vaccines

Designing precision antibiotics with inspiration from bacteria’s survival strategy

April 16, 2020

Via: FierceBiotech

Widely prescribed broad-spectrum antibiotics such as amoxicillin can kill off many types of bacteria indiscriminately, including harmless strains. But that can lead to resistance that bugs can pass on to other pathogenic bacteria. Compounds that target specific bacterial infections instead […]

Industry, News, Pharma, Pricing, Regulations

Amid coronavirus fears, a generics giant pledges price stability

February 27, 2020

Via: Biopharma Dive

A Sandoz spokesperson confirmed to BioPharma Dive that the company conducted an internal assessment of its marketed products to come up with a list of “essential” drugs that could help patients infected with SARS-CoV-2. The list includes priority antibiotics, hospital […]